Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,174
Total Claims
$392K
Drug Cost
352
Beneficiaries
$1,112
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-1%
Cost per patient vs peers
$1,112 vs $1,128 avg
+19%
Brand preference vs peers
10.0% vs 8.4% avg
Brand vs Generic
Brand: 899 claims · $286K
Generic: 8,100 claims · $101K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 29 | $33K |
| Ticagrelor | 63 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 58 | $20K |
| Insulin Nph Hum/Reg Insulin Hm | 56 | $19K |
| Dapagliflozin Propanediol | 28 | $18K |
| Insulin Lispro | 33 | $14K |
| Sitagliptin Phosphate | 15 | $12K |
| Apixaban | 21 | $12K |
| Sitagliptin Phos/Metformin Hcl | 26 | $12K |
| Levothyroxine Sodium | 143 | $8,443 |
| Fluticasone/Vilanterol | 13 | $7,508 |
| Sitagliptin Phos/Metformin Hcl | 11 | $6,089 |
| Saxagliptin Hcl | 12 | $5,935 |
| Insulin Nph Human Isophane | 27 | $5,600 |
| Atorvastatin Calcium | 701 | $5,260 |
Prescribing Profile
Patient Profile
72
Avg Age
55%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data